Brimonidine and pupillary diameter

Ophthalmology. 1998 Aug;105(8):1352-3. doi: 10.1016/S0161-6420(98)98006-X.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic alpha-Agonists / administration & dosage*
  • Adrenergic alpha-Agonists / adverse effects
  • Brimonidine Tartrate
  • Dose-Response Relationship, Drug
  • Glaucoma, Open-Angle / drug therapy*
  • Humans
  • Intraocular Pressure / drug effects
  • Ocular Hypertension / drug therapy*
  • Ophthalmic Solutions
  • Pupil / drug effects*
  • Quinoxalines / administration & dosage*
  • Quinoxalines / adverse effects
  • Safety

Substances

  • Adrenergic alpha-Agonists
  • Ophthalmic Solutions
  • Quinoxalines
  • Brimonidine Tartrate